Healthcare · Drug Manufacturers - General
Latest call day: 2026-08-25 · full consensus board · graded history
Price (daily close, 2026-08-24)
Today's calls AI
| Biotech · Breakout | UP 100% | Breakout — pushing above the prior channel high. AMGN ranks #1 of 8 in Biotech (100% bullish percentile, signal +0.9%), so the agent calls it UP for the next session. |
| Biotech · Donchian | UP 100% | Donchian — position within the Donchian channel. AMGN ranks #1 of 8 in Biotech (100% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · 52-Week-High | UP 100% | 52-Week-High — proximity to the trailing high. AMGN ranks #1 of 8 in Biotech (100% bullish percentile, 100% of its 52-week high), so the agent calls it UP for the next session. |
| Biotech · Low Volatility | UP 100% | Low Volatility — the low-volatility anomaly. AMGN ranks #1 of 8 in Biotech (100% bullish percentile, annualized volatility 27%), so the agent calls it UP for the next session. |
| Biotech · RSI Mean-Reversion | DOWN 100% | RSI Mean-Reversion — oversold up / overbought down. AMGN ranks #3 of 8 in Biotech (100% bearish percentile, RSI 81), so the agent calls it DOWN for the next session. |
| Biotech · Bollinger Reversion | DOWN 86% | Bollinger Reversion — fade moves outside the bands. AMGN ranks #4 of 8 in Biotech (86% bearish percentile), so the agent calls it DOWN for the next session. |
| Biotech · Dual Momentum | UP 86% | Dual Momentum — blends long + intermediate trend. AMGN ranks #2 of 8 in Biotech (86% bullish percentile, signal +22.7%), so the agent calls it UP for the next session. |
| Biotech · Mean-Reversion | DOWN 86% | Mean-Reversion — contrarian on the trailing return. AMGN ranks #4 of 8 in Biotech (86% bearish percentile, recent move +6.5%, fading it), so the agent calls it DOWN for the next session. |
| Biotech · Meta-Ensemble | UP 86% | Meta-Ensemble — a blend of this domain's strategies weighted by their recent precision. AMGN ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · OBV Trend | UP 86% | OBV Trend — on-balance-volume accumulation. AMGN ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Relative Strength | UP 86% | Relative Strength — return vs the domain median. AMGN ranks #2 of 8 in Biotech (86% bullish percentile, signal +10.2%), so the agent calls it UP for the next session. |
| Biotech · SOTA Ensemble | UP 86% | SOTA Ensemble — a purged-CV rank ensemble (gradient-boosting + ridge + momentum). AMGN ranks #2 of 8 in Biotech (86% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum | UP 71% | Momentum — trailing return (trend-following). AMGN ranks #3 of 8 in Biotech (71% bullish percentile, signal +18.7%), so the agent calls it UP for the next session. |
| Biotech · MACD | UP 57% | MACD — MACD histogram momentum crossover. AMGN ranks #4 of 8 in Biotech (57% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Volume Thrust | UP 57% | Volume Thrust — volume-confirmed accumulation. AMGN ranks #4 of 8 in Biotech (57% bullish percentile), so the agent calls it UP for the next session. |
| Biotech · Momentum Acceleration | UP 43% | Momentum Acceleration — trend speeding up. AMGN ranks #5 of 8 in Biotech (43% bullish percentile, signal -3.9%), so the agent calls it UP for the next session. |
Best agents on AMGN (graded record)
| Biotech · Meta-Ensemble | 68% | 15/22 correct | UP |
| Biotech · OBV Trend | 68% | 15/22 correct | UP |
| Biotech · Relative Strength | 68% | 15/22 correct | UP |
| Biotech · Vol-Adjusted Momentum | 64% | 14/22 correct | UP |
| Biotech · Mean-Reversion | 64% | 7/11 correct | DOWN |
| Biotech · Dual Momentum | 61% | 11/18 correct | UP |
| Biotech · 52-Week-High | 61% | 20/33 correct | UP |
| Biotech · Breakout | 60% | 9/15 correct | UP |
| Biotech · Trend Strength | 60% | 6/10 correct | UP |
| Biotech · Donchian | 59% | 22/37 correct | UP |
Recent news
How grading works: every call is locked before the open and scored on the session's open→close move — see the methodology.
Open Fortivio.AI →Model-generated predictions with a live graded record — not investment advice. 模型生成的预测，非投资建议。